RELAPSED CLL

Clinical trials for RELAPSED CLL explained in plain language.

Never miss a new study

Get alerted when new RELAPSED CLL trials appear

Sign up with your email to follow new studies for RELAPSED CLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Engineered immune cells take aim at stubborn blood cancers

Disease control Recruiting now

This early-phase trial is testing a new type of CAR-T cell therapy called LMY-920 for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or stopped responding to other treatments. The therapy uses a protein called BAFF to help th…

Matched conditions: RELAPSED CLL

Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC

RELAPSED CLL

Get alerted when new RELAPSED CLL trials appear

Engineered immune cells take aim at stubborn blood cancers